Overview
Study With a Topical Gel to Treat Common Warts in Adults
Status:
Completed
Completed
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
The primary purpose of this study is to evaluate the effectiveness in adults of four different strengths of resiquimod gel applied to common wart(s) five times a week for four weeks. A second purpose is to evaluate the safety of the drug.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Graceway Pharmaceuticals, LLC
Criteria
Inclusion Criteria:- Diagnosis of common warts
- Two forms of birth control
Exclusion Criteria:
- Pregnant or breast feeding
- Other types of warts, ie. plantar
- Currently participating in another clinical study
- Chronic viral hepatitis B or C